Skip to main content

Pfizer-BioNTech say vaccine effective against British COVID-19 variant

Pfizer and partner BioNTech say in new research published Wednesday that its coronavirus vaccine is likely to be highly effective against a COVID-19 variant first identified in Britain late last year.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.